
Layla Soroush
Examiner (ID: 14601, Phone: (571)272-5008 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1617, 1627, 1622 |
| Total Applications | 1222 |
| Issued Applications | 395 |
| Pending Applications | 172 |
| Abandoned Applications | 691 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14227157
[patent_doc_number] => 20190125751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => ANTICANCER COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/301463
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301463 | ANTICANCER COMBINATION THERAPY | May 14, 2017 | Abandoned |
Array
(
[id] => 11935078
[patent_doc_number] => 20170239228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'COMPOSITIONS OF TOLPERISONE'
[patent_app_type] => utility
[patent_app_number] => 15/589540
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12419
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589540
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/589540 | COMPOSITIONS OF TOLPERISONE | May 7, 2017 | Abandoned |
Array
(
[id] => 11834516
[patent_doc_number] => 20170216235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'ADMINISTRATION OF ADAPALENE AND BENZOYL PEROXIDE FOR THE LONG-TERM TREATMENT OF ACNE VULGARIS'
[patent_app_type] => utility
[patent_app_number] => 15/494218
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9464
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15494218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/494218 | ADMINISTRATION OF ADAPALENE AND BENZOYL PEROXIDE FOR THE LONG-TERM TREATMENT OF ACNE VULGARIS | Apr 20, 2017 | Abandoned |
Array
(
[id] => 17874232
[patent_doc_number] => 11446223
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Anti-aging composition
[patent_app_type] => utility
[patent_app_number] => 16/095765
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3832
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095765 | Anti-aging composition | Apr 6, 2017 | Issued |
Array
(
[id] => 11755936
[patent_doc_number] => 20170202803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'COMBINATION/ASSOCIATION OF ADAPALENE AND BENZOYL PEROXIDE FOR TREATING ACNE'
[patent_app_type] => utility
[patent_app_number] => 15/476241
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4145
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15476241
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/476241 | COMBINATION/ASSOCIATION OF ADAPALENE AND BENZOYL PEROXIDE FOR TREATING ACNE | Mar 30, 2017 | Abandoned |
Array
(
[id] => 14099045
[patent_doc_number] => 20190091198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => CANNABIONID AND CANNABIS-BASED COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE GASTROINTESTINAL TRACT
[patent_app_type] => utility
[patent_app_number] => 16/086338
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086338 | CANNABIONID AND CANNABIS-BASED COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE GASTROINTESTINAL TRACT | Mar 27, 2017 | Abandoned |
Array
(
[id] => 11742735
[patent_doc_number] => 20170196807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'PROPOFOL-CONTAINING OIL-IN-WATER EMULSION COMPOSITION AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/468302
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13103
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468302 | PROPOFOL-CONTAINING OIL-IN-WATER EMULSION COMPOSITION AND METHOD FOR PRODUCING SAME | Mar 23, 2017 | Abandoned |
Array
(
[id] => 11954665
[patent_doc_number] => 20170258817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'FOSFESTROL FOR USE IN CURATIVE OR PALLIATIVE TREATMENT OF PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/468646
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4201
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468646 | FOSFESTROL FOR USE IN CURATIVE OR PALLIATIVE TREATMENT OF PROSTATE CANCER | Mar 23, 2017 | Abandoned |
Array
(
[id] => 14016303
[patent_doc_number] => 20190070145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/086798
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086798 | USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS | Mar 21, 2017 | Abandoned |
Array
(
[id] => 11727950
[patent_doc_number] => 20170189393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION'
[patent_app_type] => utility
[patent_app_number] => 15/466395
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9712
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15466395
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/466395 | COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION | Mar 21, 2017 | Abandoned |
Array
(
[id] => 11941986
[patent_doc_number] => 20170246137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'SULFESTROL FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/461572
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10083
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15461572
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/461572 | SULFESTROL FOR TREATING CANCER | Mar 16, 2017 | Abandoned |
Array
(
[id] => 19310518
[patent_doc_number] => 12036312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Non-aqueous topical compositions comprising a halogenated salicylanilide
[patent_app_type] => utility
[patent_app_number] => 16/084741
[patent_app_country] => US
[patent_app_date] => 2017-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 35135
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084741 | Non-aqueous topical compositions comprising a halogenated salicylanilide | Mar 14, 2017 | Issued |
Array
(
[id] => 17874226
[patent_doc_number] => 11446217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Aerosol antidandruff composition
[patent_app_type] => utility
[patent_app_number] => 15/448911
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12206
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 262
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15448911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/448911 | Aerosol antidandruff composition | Mar 2, 2017 | Issued |
Array
(
[id] => 11941981
[patent_doc_number] => 20170246133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'TREATMENT OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ON LIPID LOWERING THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/445118
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12658
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15445118
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/445118 | TREATMENT OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ON LIPID LOWERING THERAPY | Feb 27, 2017 | Abandoned |
Array
(
[id] => 11935129
[patent_doc_number] => 20170239277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AN INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/440800
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64878
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440800
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440800 | COMPOSITIONS AND METHODS FOR TREATING AN INFECTION | Feb 22, 2017 | Abandoned |
Array
(
[id] => 16189243
[patent_doc_number] => 20200230092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => DIETARY PRODUCT DEVOID OF AT LEAST TWO NON ESSENTIAL AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 15/999666
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999666 | Dietary product devoid of at least two non essential amino acids | Feb 21, 2017 | Issued |
Array
(
[id] => 16236717
[patent_doc_number] => 20200253951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => COMBINATION OF AN ANTIALLERGIC AGENT WITH MUSCARINIC ANTAGONIST AND/OR DOPAMINERGIC AGONIST FOR USE IN PREVENTING/STOPPING OF AXIAL MYOPIA IN HUMAN
[patent_app_type] => utility
[patent_app_number] => 15/999784
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/999784 | COMBINATION OF AN ANTIALLERGIC AGENT WITH MUSCARINIC ANTAGONIST AND/OR DOPAMINERGIC AGONIST FOR USE IN PREVENTING/STOPPING OF AXIAL MYOPIA IN HUMAN | Feb 16, 2017 | Abandoned |
Array
(
[id] => 14697557
[patent_doc_number] => 10376500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Gel containing pirfenidone
[patent_app_type] => utility
[patent_app_number] => 15/435494
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 942
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435494
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435494 | Gel containing pirfenidone | Feb 16, 2017 | Issued |
Array
(
[id] => 16189291
[patent_doc_number] => 20200230140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => N3-SUBSTITUTED IMINOPYRIMIDINONES AS ANTIMALARIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/076400
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076400
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076400 | N3-substituted iminopyrimidinones as antimalarial agents | Feb 12, 2017 | Issued |
Array
(
[id] => 11618278
[patent_doc_number] => 20170128466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'USE OF CANTHAXANTHIN AND/OR 25-OH D3 FOR IMPROVED HATCHABILITY IN POULTRY'
[patent_app_type] => utility
[patent_app_number] => 15/413254
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2719
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/413254 | USE OF CANTHAXANTHIN AND/OR 25-OH D3 FOR IMPROVED HATCHABILITY IN POULTRY | Jan 22, 2017 | Abandoned |